Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Más en de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Más en de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | septiembre de 2025 | YoY |
|---|---|---|
| Ingresos | 68,1 M | - |
| Beneficio bruto | 19,52 M | - |
| Beneficio neto | -12,15 M | - |
| EBITDA | 6,65 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 12,92 M € |
Número de acciones | 497,46 M |
Máximo/mínimo de 52 semanas | 0,14 € - 0,0178 € |
| Dividendos | No |
Beta | 1,05 |
Ratio P/E | -0,15 |
Ratio PEG | 0,00 |
Ratio P/B | -0,10 |
Ratio P/S | 0,09 |
Perfil de la empresa
The Cannabist Company Holdings Inc. se dedica al cultivo, la fabricación y la provisión de productos de cannabis y servicios relacionados en Estados Unidos y a nivel internacional. La empresa ofrece productos que abarcan flores, comestibles, aceites y tabletas bajo las marcas Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press y Amber. Posee licencias en 17 jurisdicciones de Estados Unidos. La empresa era conocida anteriormente como Columbia Care Inc. y cambió su nombre a The Cannabist Company Holdings Inc. en septiembre de 2023. La compañía fue fundada en 2012 y tiene su sede en Nueva York, Nueva York.
| Nombre | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Sede | Malvern,
pa Estados Unidos |
| Sitio web | |
| Salida a bolsa | 29/04/2019 |
| Empleados | 2829 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |